Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on April 29, 2025
BridgeBio Reports First Quarter 2025 Financial Results and Business Updates
GlobeNewswire
·
April 29, 2025
- $36.7 million in first full quarter of U.S. Attruby™ net product revenue and as of April 25, 2025, 2,072 unique patient prescriptions written by 756 unique prescribers - Observational run-in study for hypochondroplasia Phase 2 trial fully enrolled …
BeautyHealth to Report First Quarter 2025 Financial Results on May 8, 2025
GlobeNewswire
·
April 29, 2025
LONG BEACH, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report first quarter 2025 financial results after market close on Thursday, May 8, 2025. The …
Artios Pharma Reports Differentiated Clinical Activity in STELLA Phase 1/2a Study for Lead Program ART0380 at the American Association for Cancer Research (AACR) Annual Meeting 2025
GlobeNewswire
·
April 29, 2025
ART0380 in combination with low-dose irinotecan demonstrated a 50% confirmed overall response rate (cORR) in patients with Ataxia-Telangiectasia Mutated (ATM)-negative1 solid tumors at the recommended Phase 2 dose (RP2D) 37% cORR observed in patients with …
Nouscom Presents Positive Final Results from Completed Phase Ib/II Study of Neoantigen Immunotherapy NOUS-209 at AACR 2025, Demonstrating a Highly Potent and Durable Immune Response in Lynch Syndrome Carriers
GlobeNewswire
·
April 29, 2025
Lynch Syndrome (LS) is a common hereditary condition that significantly increases the lifetime risk of cancer, especially colorectal and endometrial, to as high as 80% NOUS-209 is an off-the-shelf immunotherapy designed to harness the power of the immune …
GENFIT Announces Publication of the 2024 Universal Registration Document and the 2024 Annual Report on Form 20-F
GlobeNewswire
·
April 29, 2025
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), April 29, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, …
GENFIT : Mise à disposition du Document d’Enregistrement Universel 2024 et du Rapport Annuel Form 20-F 2024
GlobeNewswire
·
April 29, 2025
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 29 avril 2025 – GENFIT (Nasdaq et Euronext: GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie pouvant engager le …
Mitolyn Reviews Consumer Reports 2025 - Mitolyn Reviews And Complaints - Mitolyn Weight Loss Supplement - What Is Mitolyn - Does Mitolyn Work - Is Mitolyn Legit or Scam!
GlobeNewswire
·
April 29, 2025
Tallmadge, OH, April 29, 2025 (GLOBE NEWSWIRE) -- (When people look for weight loss supplements, their experiences and real results matter more than advertisements. Mitolyn is gaining attention, and many are asking: Does it really work? Are the results …
Best Steroid for Women for Muscle Growth and Fat Loss 2025 - Top Anabolic Steroids for Female Bodybuilders With Before and After Results - CrazyBulk
GlobeNewswire
·
April 29, 2025
New York City, April 29, 2025 (GLOBE NEWSWIRE) -- Best steroids for women for building muscle and losing fat presented by CrazyBulk Are you a female bodybuilder or athlete looking to take your physique to the next level in 2025? Building muscle and losing …
Tevogen Informs Public Shareholders About DRS Accounts And Differences to Brokerage Accounts
GlobeNewswire
·
April 29, 2025
WARREN, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today informed shareholders about several differences between holding shares in Direct Registration System (“DRS”) accounts and holding them …
NADP Advocates for Greater Access to Care through Dental Coverage
GlobeNewswire
·
April 29, 2025
DALLAS, April 29, 2025 (GLOBE NEWSWIRE) -- The National Association of Dental Plans (NADP) demonstrated its strong commitment to expanding access to dental care during its annual Advocacy in Action (AIA) event, April 2-3 in Washington, D.C. In more than …
Phenylketonuria Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight
GlobeNewswire
·
April 29, 2025
New York, USA, April 29, 2025 (GLOBE NEWSWIRE) -- Phenylketonuria Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight Phenylketonuria, which is characterized by the …
Louw Alberts Psychology Practice Rebrands from Talk It Out to Strengthen Identity
GlobeNewswire
·
April 29, 2025
Centurion, Gauteng, April 29, 2025 (GLOBE NEWSWIRE) -- Louw Alberts Psychology Practice, a renowned counselling practice based in Centurion, South Africa, has officially rebranded from its former name, Talk It Out. This strategic change aims to eliminate …
Lirum Therapeutics’ LX-101 New Positive Data Selected for Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting
GlobeNewswire
·
April 29, 2025
New York, NY, April 29, 2025 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, announced today that new positive data on LX-101 against an …
Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications
GlobeNewswire
·
April 29, 2025
MEDIA RELEASE Agreement offers rights to commercialize proposed biosimilar of Yervoy®* for treatment of variety of cancer types, targeting net reference medicine sales of USD 2.5 billion[1] Henlius to develop and manufacture biosimilar, with Sandoz to …
remMD Launches Glow Guide: A Smart Mobility Accessory Designed to Support Safer, Smarter Movement for Aging Adults
GlobeNewswire
·
April 29, 2025
New York, New York, April 29, 2025 (GLOBE NEWSWIRE) -- remMD announces the official launch of Glow Guide, a smart mobility accessory created to make nighttime movement safer and more manageable for individuals using canes, walkers, or wheelchairs. Designed …
FOXO TECHNOLOGIES INC. ANNOUNCES COMPLETION OF REVERSE STOCK SPLIT
GlobeNewswire
·
April 29, 2025
West Palm Beach, April 29, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”), today announced that effective 4.01pm Eastern Time, on April 28, 2025, (the “Effective Time”), the Company completed a 1 for 10 …
AscellaHealth Honored as Silver Stevie® Award Winner in 2025 American Business Awards®
GlobeNewswire
·
April 29, 2025
BERWYN, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, proudly announces it is the winner of a Silver Stevie® Award in the Fastest Growing Company …
Axiom Medical Marks 25 Years of Advancing Workplace Safety and Health at Annual Client Summit
GlobeNewswire
·
April 29, 2025
HOUSTON, TX, April 29, 2025 (GLOBE NEWSWIRE) -- Axiom Medical, a leader in occupational health and workplace injury case management solutions, celebrated 25 years of protecting workers and supporting employers at its 2025 Client Summit. Held in the Houston …
Affimed Shows Higher Exposure of AFM24 is Associated with Significantly Higher Response Rates and Progression-Free Survival in Refractory NSCLC Patients at AACR Annual Meeting
GlobeNewswire
·
April 29, 2025
An exposure-outcome analysis in 72 patients with refractory non-small cell lung cancer (NSCLC) who received AFM24 at 480 mg weekly demonstrates that higher drug exposure (above median) leads to improved objective response rate (33.3% vs 5.6%) and longer …
Kriya Announces Thirteen Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2025
GlobeNewswire
·
April 29, 2025
– Kriya’s platform includes fully integrated best-in-class manufacturing and research capabilities to support parallel advancement of a broad pipeline of gene therapies – – Current pipeline of gene therapies for chronic diseases spans three major …